Federica Orrù

Ruxolitinib therapy and telomere length in myelofibrosis. Caocci G, Greco M, Delogu G,
Secchi C, Perra A, Ghiani S, Orru F, Vacca A, Galimi F, La Nasa G. Blood Cancer J. 2016 Oct
7;6(10):e479. doi: 10.1038/bcj.2016.91.

Telomere length shortening is associated with treatment-free remission in chronic myeloid
leukemia patients. Caocci G, Greco M, Delogu G, Secchi C, Martino B, Labate C, Abruzzese E,
Trawinska MM, Galimberti S, Orru F, Fozza C, Gambacorti Passerini C, Galimi F, La Nasa G. J
Hematol Oncol. 2016 Jul 29;9(1):63. doi: 10.1186/s13045-016-0293-y.